Vivian R. Albert
18Patents
7h-index
19Co-inventors
59Inventor score
Filing activity: May 31, 1996 → May 15, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7402312B2 | Antibodies to vascular endothelial growth factor 2 (VEGF-2) | Chemistry; Metallurgy | 106 | Expired |
| US7348003B2 | Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors | Chemistry; Metallurgy | 90 | Expired |
| US7361341B2 | Methods of treating cancer using antibodies that immunospecifically bind to trail receptors | Chemistry; Metallurgy | 89 | Expired |
| US7208582B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 37 | Expired |
| US7550569B2 | Antibodies that specifically bind to GMAD | Chemistry; Metallurgy | 20 | Expired |
| US7850963B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 17 | Active |
| US7064189B2 | Antibodies that immunospecifically bind to trail receptors | Chemistry; Metallurgy | 7 | Expired |
| US5919653A | Nucleic acids encoding a human glycine transporter | Human Necessities | 7 | Expired |
| US5824486A | Glycine transporter-transfected cells and uses thereof | Chemistry; Metallurgy | 3 | Expired |
| US5968823A | Glycine transporter-transfected avian cells and uses thereof | Chemistry; Metallurgy | 2 | Expired |
| US6900033B2 | Methods and compositions for modulating ACE-2 activity | Chemistry; Metallurgy | 2 | Expired |
| US8216569B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 2 | Active |
| US8206708B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 2 | Active |
| US7109302B1 | Antibodies that specifically bind to GMAD | Chemistry; Metallurgy | 1 | Expired |
| US6008015A | Glycine transporter | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8784809B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 0 | Active |
| US9403905B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 0 | Active |
| US6251617A | Glycine transporter | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.